Article: Advances in Management of Bladder Cancer

Bladder cancer (BC) is a complex disease with the following presentations, which are completely different from one another: non-muscle-infiltrating bladder cancer (NMIBC) and muscle-infiltrating bladder cancer (MIBC) [...].

Citing Articles

An immunogenic cell death-related lncRNA signature correlates with prognosis and tumor immune microenvironment in bladder cancer.

Luo J, Luo F, Li Q, Liu Q, Wang J Sci Rep. 2024; 14(1):13106.

PMID: 38849410 PMC: 11161581. DOI: 10.1038/s41598-024-63852-9.

Establishment and validation of nomograms to predict the overall survival and cancer-specific survival for non-metastatic bladder cancer patients: A large population-based cohort study and external validation.

Li S, Wang J, Zhang Z, Wu Y, Liu Z, Yin Z Medicine (Baltimore). 2024; 103(11):e37492.

PMID: 38489693 PMC: 10939645. DOI: 10.1097/MD.0000000000037492.

Bladder cancer: therapeutic challenges and role of 3D cell culture systems in the screening of novel cancer therapeutics.

Farouk S, Khafaga A, Abdellatif A Cancer Cell Int. 2023; 23(1):251.

PMID: 37880676 PMC: 10601189. DOI: 10.1186/s12935-023-03069-4.

Integrated multi-omics analyses reveal Jorunnamycin A as a novel suppressor for muscle-invasive bladder cancer by targeting FASN and TOP1.

Chen R, Hao X, Chen J, Zhang C, Fan H, Lian F J Transl Med. 2023; 21(1):549.

PMID: 37587470 PMC: 10428641. DOI: 10.1186/s12967-023-04400-3.

Development and Validation of Nomograms Predicting the 5- and 8-Year Overall and Cancer-Specific Survival of Bladder Cancer Patients Based on SEER Program.

Wen P, Wen J, Huang X, Wang F J Clin Med. 2023; 12(4).

PMID: 36835849 PMC: 9962885. DOI: 10.3390/jcm12041314.

References

1.

Lee J, Choo M, Yoo S, Cho M, Son H, Jeong H . Intravesical Prostatic Protrusion and Prognosis of Non-Muscle Invasive Bladder Cancer: Analysis of Long-Term Data over 5 Years with Machine-Learning Algorithms. J Clin Med. 2021; 10(18). PMC: 8468209. DOI: 10.3390/jcm10184263. View

2.

Pichler R, Lindner A, Schafer G, Tulchiner G, Staudacher N, Mayr M . Expression of ADAM Proteases in Bladder Cancer Patients with BCG Failure: A Pilot Study. J Clin Med. 2021; 10(4). PMC: 7917772. DOI: 10.3390/jcm10040764. View

3.

Siracusano S, Zaka A, Romantini F, Porcaro A, Vicentini C, Lonardi C . Quality of Life in Female Patients Following Ileal Neobladder and Ileal Conduit: Where Are We?. J Clin Med. 2021; 10(14). PMC: 8304698. DOI: 10.3390/jcm10143042. View

4.

Leminski A, Kaczmarek K, Michalski W, Malkiewicz B, Kotfis K, Slojewski M . The Influence of Lymph Node Count on Oncological Outcome of Radical Cystectomy in Chemotherapy Pre-Treated and Chemotherapy-Naïve Patients with Muscle Invasive Bladder Cancer. J Clin Med. 2021; 10(21). PMC: 8584881. DOI: 10.3390/jcm10214923. View

5.

Yu J, Hong B, Park J, Lee Y, Hwang J, Kong Y . Comparison of a Significant Decline in the Glomerular Filtration Rate between Ileal Conduit and Ileal Neobladder Urinary Diversions after Radical Cystectomy: A Propensity Score-Matched Analysis. J Clin Med. 2020; 9(7). PMC: 7408753. DOI: 10.3390/jcm9072236. View